Infiltrative basal cell carcinoma often looks like a flat, white or waxy patch that resembles a scar, with no clearly defined border. Unlike the more common nodular type of basal cell carcinoma, which forms an obvious pearly bump, the infiltrative subtype tends to blend into surrounding skin, making it one of the hardest skin cancers to spot with the naked eye.
The Scar-Like Appearance
The hallmark of infiltrative basal cell carcinoma is its resemblance to scar tissue. It typically appears as a flat or slightly depressed, waxy plaque that’s pale, white, or skin-colored. The surface may look shiny or have a slightly translucent quality. Because it lacks the raised, pearly border that makes other basal cell carcinomas easier to recognize, many people dismiss it as a scar from an old injury they’ve forgotten about, or as a patch of dry skin that won’t resolve.
The edges are the most telling feature. Where a common basal cell carcinoma has a smooth, rolled border you can trace with your finger, the infiltrative subtype has irregular, blurry margins that seem to fade into the surrounding skin. Under a microscope, this makes sense: the tumor grows in jagged, finger-like strands that push outward unevenly rather than forming a compact ball. Those irregular strands of tumor cells extend well beyond what’s visible on the surface, which is why the cancer often turns out to be larger than it appears.
How It Differs on Different Skin Tones
On lighter skin, infiltrative basal cell carcinoma typically looks white, pale pink, or simply skin-colored. It may have a waxy sheen. Tiny blood vessels (fine, branching red lines) sometimes appear across the surface, though they’re less prominent than in the nodular subtype.
On brown and Black skin, basal cell carcinoma in general tends to appear brown or glossy black, sometimes with dark spots. The translucent quality is still present, but the branching blood vessels are harder to see against darker skin. This contributes to delayed diagnosis in people with darker skin tones, since the lesion can look like a minor discoloration rather than a cancer.
Physical Symptoms That Accompany the Appearance
Infiltrative basal cell carcinoma doesn’t always stay flat and painless. As it progresses, it may develop a central ulcer, a small open sore that oozes clear fluid or bleeds when touched. Some people notice the area crusts over repeatedly, appearing to heal but then breaking down again over weeks or months. This cycle of crusting and re-opening is a key warning sign for any skin cancer, but it’s especially significant with the infiltrative type because the surrounding skin may still look deceptively normal.
The lesion can also become itchy or painful, particularly once ulceration develops. If infection sets in at the ulcer site, there may be additional redness, swelling, or discharge. But in its early stages, infiltrative BCC is often completely painless, which is another reason it gets overlooked.
Where It Typically Develops
Like other basal cell carcinomas, the infiltrative subtype most commonly appears on sun-exposed areas, particularly the face. The central face is especially vulnerable: the nose, around the eyes, the lips, and the ears. These areas receive cumulative sun exposure over a lifetime, and the skin there is relatively thin, giving the tumor less resistance as it spreads. Infiltrative BCC can also develop on the neck, scalp, and less commonly on the trunk or limbs.
Why It’s Harder to Treat Than Other Types
The blurry, ill-defined borders aren’t just a visual nuisance. They’re the main reason infiltrative basal cell carcinoma is classified as an aggressive subtype. Because the tumor’s true edges extend beyond what’s visible, it’s more likely to be incompletely removed during surgery. When tumor cells are left behind at the margins, the cancer comes back.
Aggressive subtypes like infiltrative BCC account for as much as 65% of recurrent basal cell carcinomas. These recurrences often develop without obvious early symptoms, which can delay re-diagnosis. For this reason, Mohs surgery, a technique where the surgeon examines tissue layer by layer during the procedure, is generally preferred. With Mohs, the five-year recurrence rate for a first-time lesion drops to about 1%. Standard surgical excision and radiation therapy carry higher recurrence rates, and less precise methods like freezing (cryotherapy) have seen recurrence rates as high as 39% in prospective trials.
What to Actually Watch For
The challenge with infiltrative basal cell carcinoma is that it doesn’t look alarming at first glance. It won’t necessarily form the classic pearly bump or dark mole that most people associate with skin cancer. Instead, watch for these subtle changes:
- A flat, firm patch that looks like a scar but has no history of injury at that site
- A waxy or shiny area that’s paler than surrounding skin and doesn’t improve over time
- A sore that won’t heal or that repeatedly crusts, bleeds, and reopens over weeks
- A slowly expanding patch with edges that are hard to define clearly
- Fine branching blood vessels visible across the surface of an otherwise flat lesion
Any skin change that persists for more than a few weeks without explanation warrants a closer look, particularly on the face and other sun-exposed areas. Because the infiltrative subtype is so easy to mistake for benign skin changes, a biopsy is the only definitive way to confirm the diagnosis. The visual appearance can raise suspicion, but the microscopic growth pattern is what ultimately identifies this specific subtype and determines how aggressively it needs to be treated.